United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 1 minute read Pharma Industry News Merck to acquire Caraway Therapeutics in $610m deal for neurodegenerative disease treatments Merck and Caraway Therapeutics, Inc. have announced a definitive agreement in which Merck, through a subsidiary, will acquire… byPallavi MadhirajuNovember 22, 2023